In an otherwise healthy adult with stage 1‑2 hypertension not taking antihypertensive medication, can beetroot (dietary nitrate) be used to lower blood pressure, and what dosage and monitoring guidelines are recommended?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Beetroot for Blood Pressure Management in Stage 1-2 Hypertension

Beetroot juice can be used as a supplementary dietary intervention in adults with stage 1-2 hypertension not on medication, providing approximately 4-5 mmHg systolic blood pressure reduction, but it should never replace the six primary lifestyle interventions proven to deliver larger reductions.

Guideline-Supported Position

Beetroot is explicitly recognized as a beneficial supplementary intervention, not a primary treatment. The 2020 International Society of Hypertension guidelines specifically recommend increasing intake of vegetables high in nitrates known to reduce blood pressure, such as leafy vegetables and beetroot, and list beetroot juice among beneficial beverages 1. However, the 2017 ACC/AHA guidelines classify beetroot and other dietary supplements (garlic, dark chocolate, tea) as having "less persuasive" clinical trial evidence compared to the six core interventions 1.

Prioritize These Six Primary Interventions First

Before or alongside beetroot supplementation, ensure implementation of guideline-recommended interventions that deliver substantially larger blood pressure reductions 1:

  • DASH diet: 11 mmHg systolic reduction in hypertensives, 3 mmHg in normotensives 1
  • Sodium reduction (to <1500 mg/day): 5-6 mmHg systolic reduction 1
  • Weight loss: ~1 mmHg reduction per kilogram lost 1
  • Potassium supplementation (3500-5000 mg/day): 4-5 mmHg reduction 1
  • Aerobic exercise (90-150 min/week): 5-8 mmHg systolic reduction 1
  • Alcohol moderation (≤2 drinks/day men, ≤1 women): 4 mmHg reduction 1

Evidence-Based Dosing for Beetroot

The most robust evidence supports 200-800 mg dietary nitrate daily (approximately 250 mL beetroot juice) for sustained blood pressure reduction 2, 3.

Specific Dosing Protocol

  • Daily dose: 250 mL beetroot juice containing approximately 400-500 mg (12.9 mmol) dietary nitrate 4, 3
  • Timing: Any convenient time of day to establish habitual intake; no specific timing required 5
  • Duration: Minimum 7 days for effect, with sustained benefit demonstrated up to 4 weeks without tachyphylaxis 3
  • Expected reduction: 4-5 mmHg systolic, 2-4 mmHg diastolic blood pressure 2, 4, 3

Key Evidence Supporting Efficacy

The highest-quality recent meta-analysis (2024) of 11 randomized controlled trials in 349 hypertensive patients demonstrated beetroot juice reduced clinical systolic blood pressure by 5.31 mmHg (95% CI -7.46 to -3.16) compared to placebo, though certainty of evidence was rated as low 2. A 2015 phase 2 randomized controlled trial in 68 hypertensive patients showed 4-week daily supplementation reduced clinic BP by 7.7/2.4 mmHg, 24-hour ambulatory BP by 7.7/5.2 mmHg, and home BP by 8.1/3.8 mmHg with no tachyphylaxis 3.

Critical Clinical Considerations

When Beetroot Works Best

Beetroot appears most effective in untreated or uncontrolled hypertension 6, 4. A 2017 study found significant blood pressure reductions only in uncontrolled hypertensives (nighttime diastolic BP -6 mmHg), with minimal effect in controlled hypertensives 6. A 2018 crossover trial in treated but uncontrolled hypertensives demonstrated 24-hour systolic BP reduction of 8 mmHg and diastolic reduction of 4 mmHg 4.

Important Negative Evidence

One high-quality 2015 randomized controlled trial found no blood pressure effect in treated hypertensive patients despite confirmed increases in plasma nitrate/nitrite 7. This suggests beetroot may be less effective as add-on therapy in patients already achieving some blood pressure control with medication 7.

Monitoring Guidelines

Initial Assessment (Before Starting)

  • Establish baseline blood pressure using home blood pressure monitoring or 24-hour ambulatory monitoring 3
  • Document current antihypertensive medications and doses 6, 4
  • Assess renal function if history of kidney disease 5

Follow-Up Monitoring

  • Stage 1 hypertension with <10% 10-year ASCVD risk: Repeat blood pressure evaluation within 3-6 months of initiating nonpharmacological therapy including beetroot 1
  • Stage 1 hypertension with ≥10% 10-year ASCVD risk: Repeat blood pressure evaluation in 1 month; initiate pharmacotherapy alongside lifestyle interventions 1
  • Stage 2 hypertension: Immediate pharmacotherapy required; beetroot can be adjunctive only 1

Critical Safety Warnings

Do Not Use Beetroot as Monotherapy When Medication is Indicated

Patients with stage 2 hypertension (≥140/90 mmHg) require immediate pharmacological treatment 1. Beetroot should never replace or delay indicated antihypertensive medication 5. The 2020 ISH guidelines explicitly state that drug treatment is essential for BP ≥160/100 mmHg and optimal for BP 140-159/90-99 mmHg in high-risk patients 1.

Special Populations Requiring Caution

  • Patients on antihypertensive medications: Consult before adding beetroot due to potential additive blood pressure-lowering effects 5
  • Chronic kidney disease: Exercise caution with high-nitrate supplements due to potential potassium content and impaired nitrate metabolism 5

Common Pitfalls to Avoid

  1. Overestimating beetroot's effect: The 4-5 mmHg reduction is modest compared to DASH diet (11 mmHg) or sodium reduction (5-6 mmHg) 1, 2
  2. Using beetroot instead of proven interventions: Guidelines classify it as supplementary, not primary therapy 1, 5
  3. Delaying medication in stage 2 hypertension: Pharmacotherapy is mandatory and should not be postponed for dietary trials 1
  4. Expecting universal response: Evidence shows variable efficacy, with some controlled hypertensives showing no benefit 6, 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.